Shopping Cart 0
Cart Subtotal
AED 0

The Medicines Company (MDCO) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 2753

Details

Summary

The Medicines Company (TMC) is a biopharmaceutical company, which provides medical solutions for improving health conditions in patients under critical care. The company's product portfolio comprises marketed products a peptide compound that inhibits an intravenous direct thrombin and needle-free patient-controlled system for short term management of acute postoperative pain for adults requiring opioid analgesia in the hospital. Its pipeline products include an investigational anesthetic agent; and an investigational lipid-lowering drug. TMC also provides acute care generic pharmaceuticals products. The company offers its products for major therapeutic areas, which include surgery and perioperative care, acute care, and cardiovascular care. It has offices and other facilities in the US, the UK, Canada and other European countries. TMC is headquartered in Parsippany, New Jersey, the US.

The Medicines Company (MDCO)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

The Medicines Company, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

The Medicines Company, Medical Equipment Deals By Type, 2012 to YTD 2018 6

The Medicines Company, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

The Medicines Company, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

The Medicines Company, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

The Medicines Company, Medical Equipment, Deal Details 10

Venture Financing 10

Targanta Therapeutics Raises USD2.4 Million in Series A Financing 10

Partnerships 11

PhageTech Enters into Research Agreement with University of California, Irvine 11

Acquisition 12

The Medicines Company To Acquire Tenaxis Medical For USD 170 Million 12

Medicines Company Completes Acquisition Of ProFibrix For Up To USD 240 Million 13

Medicines Company Completes Acquisition Of Incline Therapeutics For USD 185 Million 15

The Medicines Company-Key Competitors 17

The Medicines Company-Key Employees 18

The Medicines Company-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 21

Financial Announcements 21

Aug 01, 2018: The Medicines Company Reports Second-Quarter 2018 Results 21

Apr 25, 2018: The Medicines Company Reports First-Quarter 2018 Results 23

Feb 21, 2018: The Medicines Company Reports Fourth-Quarter and Full-Year 2017 Business and Financial Results 25

Oct 25, 2017: The Medicines Company Reports Third-Quarter 2017 Business and Financial Results 27

Aug 09, 2017: The Medicines Company Reports Second Quarter 2017 Business and Financial Results 29

Apr 26, 2017: The Medicines Company Reports First-Quarter 2017 Financial Results 31

Feb 28, 2017: The Medicines Company Reports Fourth-Quarter and Full-Year 2016 Financial Results 32

Corporate Communications 34

Mar 27, 2018: The Medicines Company Announces Chief Financial Officer Transition 34

Feb 27, 2018: The Medicines Company Appoints Dr. Sarah Schlesinger to Its Board of Directors 35

Mar 31, 2017: The Medicines Company Appoints Paris Panayiotopoulos to Its Board of Directors 36

Appendix 37

Methodology 37

About GlobalData 37

Contact Us 37

Disclaimer 37


List Of Figure

List of Figures

The Medicines Company, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

The Medicines Company, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

The Medicines Company, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

The Medicines Company, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

The Medicines Company, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

The Medicines Company, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

The Medicines Company, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

The Medicines Company, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

The Medicines Company, Medical Equipment, Key Facts, 2017 2

The Medicines Company, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

The Medicines Company, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

The Medicines Company, Medical Equipment Deals By Type, 2012 to YTD 2018 6

The Medicines Company, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

The Medicines Company, Deals By Market, 2012 to YTD 2018 8

The Medicines Company, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Targanta Therapeutics Raises USD2.4 Million in Series A Financing 10

PhageTech Enters into Research Agreement with University of California, Irvine 11

The Medicines Company To Acquire Tenaxis Medical For USD 170 Million 12

Medicines Company Completes Acquisition Of ProFibrix For Up To USD 240 Million 13

Medicines Company Completes Acquisition Of Incline Therapeutics For USD 185 Million 15

The Medicines Company, Key Competitors 17

The Medicines Company, Key Employees 18

The Medicines Company, Subsidiaries 19

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

The Medicines Company, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

The Medicines Company (TMC) is a biopharmaceutical company, which provides medical solutions for improving health conditions in patients under critical care. The company's product portfolio comprises marketed products a peptide compound that inhibits an intravenous direct thrombin and needle-free patient-controlled system for short term management of acute postoperative pain for adults requiring opioid analgesia in the hospital. Its pipeline products include an investigational anesthetic agent; and an investigational lipid-lowering drug. TMC also provides acute care generic pharmaceuticals products. The company offers its products for major therapeutic areas, which include surgery and perioperative care, acute care, and cardiovascular care. It has offices and other facilities in the US, the UK, Canada and other European countries. TMC is headquartered in Parsippany, New Jersey, the US.

The Medicines Company (MDCO)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

The Medicines Company, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

The Medicines Company, Medical Equipment Deals By Type, 2012 to YTD 2018 6

The Medicines Company, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

The Medicines Company, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

The Medicines Company, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

The Medicines Company, Medical Equipment, Deal Details 10

Venture Financing 10

Targanta Therapeutics Raises USD2.4 Million in Series A Financing 10

Partnerships 11

PhageTech Enters into Research Agreement with University of California, Irvine 11

Acquisition 12

The Medicines Company To Acquire Tenaxis Medical For USD 170 Million 12

Medicines Company Completes Acquisition Of ProFibrix For Up To USD 240 Million 13

Medicines Company Completes Acquisition Of Incline Therapeutics For USD 185 Million 15

The Medicines Company-Key Competitors 17

The Medicines Company-Key Employees 18

The Medicines Company-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 21

Financial Announcements 21

Aug 01, 2018: The Medicines Company Reports Second-Quarter 2018 Results 21

Apr 25, 2018: The Medicines Company Reports First-Quarter 2018 Results 23

Feb 21, 2018: The Medicines Company Reports Fourth-Quarter and Full-Year 2017 Business and Financial Results 25

Oct 25, 2017: The Medicines Company Reports Third-Quarter 2017 Business and Financial Results 27

Aug 09, 2017: The Medicines Company Reports Second Quarter 2017 Business and Financial Results 29

Apr 26, 2017: The Medicines Company Reports First-Quarter 2017 Financial Results 31

Feb 28, 2017: The Medicines Company Reports Fourth-Quarter and Full-Year 2016 Financial Results 32

Corporate Communications 34

Mar 27, 2018: The Medicines Company Announces Chief Financial Officer Transition 34

Feb 27, 2018: The Medicines Company Appoints Dr. Sarah Schlesinger to Its Board of Directors 35

Mar 31, 2017: The Medicines Company Appoints Paris Panayiotopoulos to Its Board of Directors 36

Appendix 37

Methodology 37

About GlobalData 37

Contact Us 37

Disclaimer 37


List Of Figure

List of Figures

The Medicines Company, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

The Medicines Company, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

The Medicines Company, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

The Medicines Company, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

The Medicines Company, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

The Medicines Company, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

The Medicines Company, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

The Medicines Company, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

The Medicines Company, Medical Equipment, Key Facts, 2017 2

The Medicines Company, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

The Medicines Company, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

The Medicines Company, Medical Equipment Deals By Type, 2012 to YTD 2018 6

The Medicines Company, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

The Medicines Company, Deals By Market, 2012 to YTD 2018 8

The Medicines Company, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Targanta Therapeutics Raises USD2.4 Million in Series A Financing 10

PhageTech Enters into Research Agreement with University of California, Irvine 11

The Medicines Company To Acquire Tenaxis Medical For USD 170 Million 12

Medicines Company Completes Acquisition Of ProFibrix For Up To USD 240 Million 13

Medicines Company Completes Acquisition Of Incline Therapeutics For USD 185 Million 15

The Medicines Company, Key Competitors 17

The Medicines Company, Key Employees 18

The Medicines Company, Subsidiaries 19

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

The Medicines Company, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.